Back to search

Article

CDK8 and CDK19 kinases have non-redundant oncogenic functions in hepatocellular carcinoma

2019-10-01

Abstract excerpt

Hepatocellular carcinoma (HCC) is a common cancer with high mortality. The limited therapeutic options for advanced disease include treatment with Sorafenib, a multi-kinase inhibitor whose targets include the Mediator kinase CDK8. Since CDK8 has reported oncogenic activity in Wnt-dependent colorectal cancer, we investigated whether it is also involved in HCC. We find that CDK8 and its paralogue CDK19 are significa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2abfde29-05a8-5d34-a6e0-943da6647058
DOI
10.1101/789586
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CDK8 and CDK19 kinases have non-redundant oncogenic functions in hepatocellular carcinomaDOI 10.1101/789586
Select a neighboring publication to make it the new centre.